Like on Facebook Join the LinkedIn Group
Past Webinars (past 3 years)
A complete list of all webinars can be accessed in Members Only Webinar Library. We welcome other networks and communities to contact us with proposals for joint webinars, ASCPT meeting sessions, or other collaborative activities that foster engagement and promote interaction around shared areas of interest.
Access Library
2025
- Probe Substrates for Clinical CYP2C8-Mediated Drug-Drug Interaction Studies: From Repaglinide to Daprodustat
2024
- Applications of Mechanistic Statis and Dynamic Models for Transporters-Mediated Drug Interaction Assessments (PBPK) Modeling to Inform Regulatory Decision for Cytokine-Mediated Drug Interactions
- The Use of Real-World Evidence (RWE) for Regulatory Decision-Making
2023
- Trainee Showcase: Function and Regulation of Membrane Transporters in Disease
- Trainee Showcase: Recent Advances in Transporters and Toxicity
- Are Coproporphyrins (CP) the Only Game in Town? Jumping Into the Bile Acid Pool to Identify Non-CPI/III Biomarkers for Assessing OATP1B Mediated Drug-Drug Interactions
Past White Papers (past 2 years)
2025
- Asano S, Galetin A, Tomita Y, Giacomini KM, Chu X, Yang X, Nakamura T, Kusuhara H, Sugiyama Y. Predicting OCT2/MATEs-Mediated Drug Interactions in Healthy Volunteers and Patients with Chronic Kidney Disease: Insights from Extended Clearance Concept, Endogenous Biomarkers, and In Vitro Inhibition Studies (Perspectives from the International Transporter Consortium). Clin Pharmacol Ther. 2025 May; online
2024
- Galetin A, Brouwer KLR, Tweedie D, Yoshida K, Sjöstedt N, Aleksunes L, Chu X, Evers R, Hafey MJ, Lai Y, Matsson P, Riselli A, Shen H, Sparreboom A, Varma MVS, Yang J, Yang X, Yee SW, Zamek-Gliszczynski MJ, Zhang L, Giacomini KM. Membrane transporters in drug development and as determinants of precision medicine. Nat Rev Drug Discov. 2024 Apr;23(4):255-280. PMID: 38267543